Results 201 to 210 of about 12,956,457 (322)

Baseline plasma p-tau217/Aβ42 as a sensitive marker for the severity of Alzheimer's disease continuum. [PDF]

open access: yesJ Transl Med
Liu WZ   +9 more
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Correction to: Greater ambient air pollution exposure is associated with worse respiratory symptoms in men and women with HIV and chronic lung disease: a cohort study. [PDF]

open access: yesRespir Res
Wilgus ML   +25 more
europepmc   +1 more source

Guru Dalam UU No.14/2005 [PDF]

open access: yes, 2005
Usa, M. (Muslih)
core  

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Correction: Quality of life improvements associated with weight loss using a novel shape-shifting hydrogel capsule: RESET study results. [PDF]

open access: yesInt J Obes (Lond)
Kushner RF   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy